SLEEP 2025

June 08-11, 2025
Seattle, WA

39th Annual Meeting of the American Academy of Sleep Medicine
Explore more Sleep congress materials
Material Type

Results(24)

Neuroscience
Sodium-Associated Comorbidity Risk Profiles in Individuals With Narcolepsy and Idiopathic Hypersomnia in the US
Author(s): Sarah C. Markt, ScD, MPH, Caroleen Drachenberg, PhD, MSPH, Richard J. Kovacs, MD et al.
Subjective Sleep Quality With Low-Sodium Oxybate Treatment in Narcolepsy: Results From the DUET Study
Author(s): R. Bart Sangal, MD, Emmanuel Mignot, MD, PhD, Chad M. Ruoff, MD et al.
Nocturnal Spontaneous Arousals in People With Narcolepsy and Idiopathic Hypersomnia Treated With Low-Sodium Oxybate
Author(s): Chad M. Ruoff, MD, David T. Plante, MD, PhD, Deborah A. Nichols, MS et al.
Demographic and Clinical Characteristics in Narcolepsy and Idiopathic Hypersomnia at Treatment Initiation
Author(s): Virend K. Somers, MD, PhD, Sarah C. Markt, ScD, MPH, Shaina Desai, MPH et al.
Real-World Experience and Satisfaction With Low-Sodium Oxybate in Narcolepsy: Interim Results From LYRICAL
Author(s): Caroleen Drachenberg, PhD, MSPH, Jennifer Cline, MBA, Jennifer D’Souza, PhD, MPH et al.
Sleep Architecture With Low-Sodium Oxybate Treatment in Idiopathic Hypersomnia: Results From the DUET Study
Author(s): Alyssa Cairns, PhD, Richard K. Bogan, MD, FCCP, FAASM, Nancy Foldvary-Schaefer, DO, MS et al.
Effectiveness and Safety of Low-Sodium Oxybate Dosages >9 Grams in Study Participants With Narcolepsy
Author(s): Jerald H. Simmons, MD, et al.
Impact of Switching From High- to Low-Sodium Oxybate on Ambulatory Blood Pressure in Patients With Narcolepsy
Author(s): Virend K. Somers, MD, PhD, et al.
Idiopathic Hypersomnia Treatment Trends and Change in Alerting Agent Use After Low-Sodium Oxybate Initiation
Author(s): Marisa Whalen, PharmD, Sarah C. Markt, ScD, MPH, Jessica K. Alexander, PhD et al.